GlassScriptPhysician profile
Jake Michael Karels
NPI 1548686447
$1,145.57
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $87.96 · 2023: $362 · 2024: $695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $189.64 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $163.60 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $143.05 | 2024 | Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $92.19 | 2023-2024 | Rexulti |
| Exact Sciences Corporation | $79.12 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $76.21 | 2023-2024 | Mounjaro, Jardiance, Zepbound |
| Glaxosmithkline, LLC. | $66.11 | 2022-2024 | Shingrix, Arexvy |
| Pfizer INC. | $53.27 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.31 | 2023-2024 | Jardiance |
| Axsome Therapeutics, INC. | $45.23 | 2024 | Auvelity |
| Si-Bone, INC. | $38.88 | 2023 | |
| Merck Sharp & Dohme LLC | $36.29 | 2024 | Gardasil 9, Capvaxive, Gardasil |
| Boston Scientific Corporation | $24.77 | 2022 | |
| Bausch Health US, LLC | $24.29 | 2023 | Aplenzin, Wellbutrin |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.98 | 2024 | Caplyta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $15.63 | 2022 | |
| Ironshore Pharmaceuticals INC. | $14.75 | 2022 | |
| Amgen INC. | $14.25 | 2024 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jake Karels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.